Drugs / XNW7201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03901950 | Jul 2019 → Dec 2021 | cancer | Evopoint Biosciences Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XNW7201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03901950 ↗ |
| Action | Inhibit | “A wnt pathway inhibitor” NCT03901950 ↗ |
| Route | Oral | “XNW7201 tablets” NCT03901950 ↗ |